Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

NCT06229210 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder
Autism Spectrum Disorder

Interventions

DRUG: Lumateperone

Sponsor

Intra-Cellular Therapies, Inc.